Contraceptive efficacy of norethindrone acetate (ENTA) implant: its release rate and fertility potential.
Shahani
S M
SM
Kulkarni
P P
PP
Laumas
K R
KR
D000013:Congenital Abnormalities; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D008597:Menstrual Cycle; D008598:Menstruation; D009640:Norethindrone; D012098:Reproduction; D012102:Reproductive Control Agents; D012106:Research
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D012102:Reproductive Control Agents; D009640:Norethindrone
Clinical Research; Congenital Abnormalities; Contraception; Contraception Failure; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Agents--side effects; Contraceptive Implants--side effects; Contraceptive Methods--side effects; Contraceptive Usage; Evaluation; Family Planning; Menstrual Cycle; Menstruation; Norethindrone Acetate--side effects; Norethindrone--side effects; Reproduction; Reproductive Control Agents; Research Methodology